Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
24339 | 315 | 30.9 | 63% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
408 | 3 | CHIM BIOINORGAN//POLO SCI//CARBONIC ANHYDRASE | 29468 |
1816 | 2 | INTERNATIONAL JOURNAL OF HYPERTHERMIA//HYPERTHERMIA//ISOLATED LIMB PERFUSION | 6226 |
24339 | 1 | LONIDAMINE//IONIDAMINE//ADVANCED BREAST CANCER CHEMOTHERAPY | 315 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LONIDAMINE | authKW | 7537825 | 31% | 80% | 97 |
2 | IONIDAMINE | authKW | 258496 | 1% | 67% | 4 |
3 | ADVANCED BREAST CANCER CHEMOTHERAPY | authKW | 193874 | 1% | 100% | 2 |
4 | ANTISPERMATOGENIC DRUGS | authKW | 193874 | 1% | 100% | 2 |
5 | LONIDAMINE AND BREAST CANCER | authKW | 193874 | 1% | 100% | 2 |
6 | LONIDAMINE THERAPY | authKW | 193874 | 1% | 100% | 2 |
7 | MALE PUBERTAL MICE | authKW | 193874 | 1% | 100% | 2 |
8 | MITOMYCIN C DRUG COMBINATION | authKW | 193874 | 1% | 100% | 2 |
9 | PENN SUPERFUND TRAINING PROGRAM | address | 193874 | 1% | 100% | 2 |
10 | TOLNIDAMINE | authKW | 193874 | 1% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 4964 | 64% | 0% | 202 |
2 | Pharmacology & Pharmacy | 157 | 15% | 0% | 48 |
3 | Pathology | 77 | 5% | 0% | 16 |
4 | CYTOLOGY & HISTOLOGY | 48 | 1% | 0% | 2 |
5 | Radiology, Nuclear Medicine & Medical Imaging | 30 | 5% | 0% | 16 |
6 | Microscopy | 7 | 1% | 0% | 2 |
7 | Biophysics | 7 | 3% | 0% | 9 |
8 | Reproductive Biology | 7 | 1% | 0% | 4 |
9 | Obstetrics & Gynecology | 7 | 2% | 0% | 7 |
10 | Andrology | 6 | 0% | 0% | 1 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PENN SUPERFUND TRAINING PROGRAM | 193874 | 1% | 100% | 2 |
2 | DIPARTIMENTO MED SPERIMENTALE SANITA PUBBLICA | 96937 | 0% | 100% | 1 |
3 | EXCELLENCE ENVIRONM TOXICOL MED | 96937 | 0% | 100% | 1 |
4 | INVEST BIOENERGET CIBIERG | 96937 | 0% | 100% | 1 |
5 | IST CLIN MED IV | 96937 | 0% | 100% | 1 |
6 | IST ISTOL EMBRIOL LARGO FRANCESCO VITO 1 | 96937 | 0% | 100% | 1 |
7 | ULTRASTRUCT VIALE REGINA ELENA 299 | 96937 | 0% | 100% | 1 |
8 | INTERDISCIPLINARY MALE CONTRACEPT DRUG | 64622 | 1% | 33% | 2 |
9 | ASL6 | 48468 | 0% | 50% | 1 |
10 | HUMAN BIOPATHOL HAEMATOL | 48468 | 0% | 50% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ONCOLOGY | 11928 | 7% | 1% | 22 |
2 | EXPERIMENTAL AND MOLECULAR PATHOLOGY | 7120 | 4% | 1% | 14 |
3 | CHEMOTHERAPY | 3812 | 3% | 0% | 10 |
4 | TUMORI | 3495 | 4% | 0% | 13 |
5 | ANTICANCER RESEARCH | 3156 | 8% | 0% | 25 |
6 | SEMINARS IN ONCOLOGY | 3134 | 4% | 0% | 13 |
7 | INTERNATIONAL JOURNAL OF ONCOLOGY | 2590 | 5% | 0% | 16 |
8 | ONCOLOGY RESEARCH | 1287 | 1% | 0% | 4 |
9 | INTERNATIONAL JOURNAL OF HYPERTHERMIA | 1242 | 2% | 0% | 5 |
10 | CANCER BIOTHERAPY | 1018 | 0% | 1% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LONIDAMINE | 7537825 | 31% | 80% | 97 | Search LONIDAMINE | Search LONIDAMINE |
2 | IONIDAMINE | 258496 | 1% | 67% | 4 | Search IONIDAMINE | Search IONIDAMINE |
3 | ADVANCED BREAST CANCER CHEMOTHERAPY | 193874 | 1% | 100% | 2 | Search ADVANCED+BREAST+CANCER+CHEMOTHERAPY | Search ADVANCED+BREAST+CANCER+CHEMOTHERAPY |
4 | ANTISPERMATOGENIC DRUGS | 193874 | 1% | 100% | 2 | Search ANTISPERMATOGENIC+DRUGS | Search ANTISPERMATOGENIC+DRUGS |
5 | LONIDAMINE AND BREAST CANCER | 193874 | 1% | 100% | 2 | Search LONIDAMINE+AND+BREAST+CANCER | Search LONIDAMINE+AND+BREAST+CANCER |
6 | LONIDAMINE THERAPY | 193874 | 1% | 100% | 2 | Search LONIDAMINE+THERAPY | Search LONIDAMINE+THERAPY |
7 | MALE PUBERTAL MICE | 193874 | 1% | 100% | 2 | Search MALE+PUBERTAL+MICE | Search MALE+PUBERTAL+MICE |
8 | MITOMYCIN C DRUG COMBINATION | 193874 | 1% | 100% | 2 | Search MITOMYCIN+C+DRUG+COMBINATION | Search MITOMYCIN+C+DRUG+COMBINATION |
9 | TOLNIDAMINE | 193874 | 1% | 100% | 2 | Search TOLNIDAMINE | Search TOLNIDAMINE |
10 | TUMOR DE ENERGIZATION | 193874 | 1% | 100% | 2 | Search TUMOR+DE+ENERGIZATION | Search TUMOR+DE+ENERGIZATION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DI COSIMO, S , FERRETTI, G , PAPALDO, P , CARLINI, P , FABI, A , COGNETTI, F , (2003) LONIDAMINE: EFFICACY AND SAFETY IN CLINICAL TRIALS FOR THE TREATMENT OF SOLID TUMORS.DRUGS OF TODAY. VOL. 39. ISSUE 3. P. 157-173 | 43 | 90% | 72 |
2 | NATH, K , GUO, LL , NANCOLAS, B , NELSON, DS , SHESTOV, AA , LEE, SC , ROMAN, J , ZHOU, R , LEEPER, DB , HALESTRAP, AP , ET AL (2016) MECHANISM OF ANTINEOPLASTIC ACTIVITY OF LONIDAMINE.BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. VOL. 1866. ISSUE 2. P. 151 -162 | 44 | 53% | 0 |
3 | PRICE, GS , CLINE, JM , PAGE, RL , RIVIERE, JE , THRALL, DE , (1998) POTENTIAL COMPLICATIONS ASSOCIATED WITH NORMOTHERMIC LONIDAMINE INFUSION AND WITH SYSTEMIC ACIDOSIS IN DOGS RECEIVING LONIDAMINE DURING WHOLE BODY HYPERTHERMIA (WBH).INTERNATIONAL JOURNAL OF HYPERTHERMIA. VOL. 14. ISSUE 3. P. 271-283 | 36 | 88% | 0 |
4 | PRICE, GS , PAGE, RL , RIVIERE, JE , CLINE, JM , THRALL, DE , (1996) PHARMACOKINETICS AND TOXICITY OF ORAL AND INTRAVENOUS LONIDAMINE IN DOGS.CANCER CHEMOTHERAPY AND PHARMACOLOGY. VOL. 38. ISSUE 2. P. 129-135 | 28 | 93% | 20 |
5 | TEICHER, BA , (1994) LONIDAMINE - IN-VITRO IN-VIVO CORRELATIONS.EUROPEAN JOURNAL OF CANCER. VOL. 30A. ISSUE 10. P. 1411-1413 | 29 | 97% | 15 |
6 | DELENA, M , LORUSSO, V , BOTTALICO, C , BRANDI, M , DEMITRIO, A , CATINO, A , GUIDA, M , LATORRE, A , LEONE, B , VALLEJO, C , ET AL (1997) REVERTANT AND POTENTIATING ACTIVITY OF LONIDAMINE IN PATIENTS WITH OVARIAN CANCER PREVIOUSLY TREATED WITH PLATINUM.JOURNAL OF CLINICAL ONCOLOGY. VOL. 15. ISSUE 10. P. 3208-3213 | 26 | 87% | 18 |
7 | CERVANTES-MADRID, D , ROMERO, Y , DUENAS-GONZALEZ, A , (2015) REVIVING LONIDAMINE AND 6-DIAZO-5-OXO-L-NORLEUCINE TO BE USED IN COMBINATION FOR METABOLIC CANCER THERAPY.BIOMED RESEARCH INTERNATIONAL. VOL. . ISSUE . P. - | 36 | 36% | 4 |
8 | FRASSINETI, GL , NANNI, O , MILANDRI, C , FERRARI, M , DEMATTEIS, A , MUSTACCHI, G , CARIELLO, S , MASCIA, V , SANTORO, A , AMADORI, D , ET AL (1994) LONIDAMINE IN MODULATION OF RESPONSE TO ADRIAMYCIN IN ADVANCED BREAST-CANCER - PRELIMINARY-RESULTS.INTERNATIONAL JOURNAL OF ONCOLOGY. VOL. 4. ISSUE . P. 741-746 | 25 | 100% | 1 |
9 | SILVESTRINI, R , GORNATI, D , ZAFFARONI, N , BEARZATTO, A , DEMARCO, C , (1997) MODULATION BY LONIDAMINE ON THE COMBINED ACTIVITY OF CISPLATIN AND EPIDOXORUBICIN IN HUMAN BREAST CANCER CELLS.BREAST CANCER RESEARCH AND TREATMENT. VOL. 42. ISSUE 2. P. 103-112 | 21 | 100% | 5 |
10 | MORAGLIO, L , BREMA, F , PASTORINO, G , MARTINI, MC , VALLAURI, M , (1995) COMBINATION OF EPIRUBICIN AND LONIDAMINE FOR TREATMENT OF ADVANCED BREAST-CANCER.TUMORI. VOL. 81. ISSUE 2. P. 107-111 | 24 | 92% | 5 |
Classes with closest relation at Level 1 |